(Q42053683)

15 October 2017

title

Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol (English)

1 reference

15 October 2017

1 reference

1 reference

Richards JR

1

1 reference

15 October 2017

Derlet RW

series ordinal

2

1 reference

15 October 2017

Duncan DR

series ordinal

3

1 reference

15 October 2017

language of work or name

1 reference

1 July 1998

1 reference

Journal of Emergency Medicine

15 October 2017

published in

1 reference

15 October 2017

volume

16

1 reference

15 October 2017

issue

4

1 reference

15 October 2017

page(s)

567-573

1 reference

Rapid tranquilization of the violent patient

15 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Lorazepam for the treatment of psychotic agitation

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Haloperidol for sedation of disruptive emergency patients

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Droperidol versus haloperidol for chemical restraint of agitated and combative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Droperidol in acutely agitated patients. A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Absorption, Metabolism and Excretion of Droperidol by Human Subjects Folloiwing Intramuscular and Intravenous Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Effects of droperidol on sympathetic activity and baroreflex control of heart rate in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

The effect of droperidol on objective markers of patient cooperation and vital signs during esophagogastroduodenoscopy: a randomized, double-blind, placebo-controlled, prospective investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Droperidol causes a dose-dependent prolongation of the QT interval

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Amphetamine toxicity: experience with 127 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Methamphetamine-induced choreoathetosis and rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Cardiac lesions and their reversibility after long term administration of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Early post-treatment with haloperidol retards induction of methamphetamine sensitization in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Inhibition of methamphetamine sensitization by post-methamphetamine treatment with SCH 23390 or haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

Protection against d-amphetamine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2898%2900045-6

7 January 2021

10.1016/S0736-4679(98)00045-6

Identifiers

DOI

1 reference

15 October 2017

1 reference